These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30551280)

  • 1. [Advances in aspirin-exacerbated respiratory disease (AERD)].
    Higashi N; Mitsui C; Taniguchi M
    Nihon Rinsho; 2016 Oct; 74(10):1683-1687. PubMed ID: 30551280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
    Buchheit KM; Cahill KN; Katz HR; Murphy KC; Feng C; Lee-Sarwar K; Lai J; Bhattacharyya N; Israel E; Boyce JA; Laidlaw TM
    J Allergy Clin Immunol; 2016 May; 137(5):1566-1576.e5. PubMed ID: 26691435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin-Exacerbated Respiratory Disease.
    Walgama ES; Hwang PH
    Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Aspirin-Exacerbated Respiratory Disease.
    Woessner KM
    Curr Allergy Asthma Rep; 2017 Jan; 17(1):2. PubMed ID: 28097500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin-exacerbated respiratory disease.
    Wangberg H; White AA
    Curr Opin Immunol; 2020 Oct; 66():9-13. PubMed ID: 32299015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
    Laidlaw TM; Buchheit KM; Cahill KN; Hacker J; Cho L; Cui J; Feng C; Chen CC; Le M; Israel E; Boyce JA
    J Allergy Clin Immunol; 2023 Sep; 152(3):700-710.e3. PubMed ID: 37068712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease.
    Luskin K; Thakrar H; White A
    Immunol Allergy Clin North Am; 2020 May; 40(2):329-343. PubMed ID: 32278455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil production of prostaglandin D
    Feng X; Ramsden MK; Negri J; Baker MG; Payne SC; Borish L; Steinke JW
    J Allergy Clin Immunol; 2016 Oct; 138(4):1089-1097.e3. PubMed ID: 27423494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper airways in aspirin-exacerbated respiratory disease.
    Choi JH; Kim JH; Park HS
    Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.
    Eastman JJ; Cavagnero KJ; Deconde AS; Kim AS; Karta MR; Broide DH; Zuraw BL; White AA; Christiansen SC; Doherty TA
    J Allergy Clin Immunol; 2017 Jul; 140(1):101-108.e3. PubMed ID: 28279492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular interactions in aspirin-exacerbated respiratory disease.
    Badrani JH; Doherty TA
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):65-70. PubMed ID: 33306487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
    Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
    J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
    Stevens WW; Peters AT; Hirsch AG; Nordberg CM; Schwartz BS; Mercer DG; Mahdavinia M; Grammer LC; Hulse KE; Kern RC; Avila P; Schleimer RP
    J Allergy Clin Immunol Pract; 2017; 5(4):1061-1070.e3. PubMed ID: 28286156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Abud EM; White AA
    Curr Allergy Asthma Rep; 2024 Feb; 24(2):73-80. PubMed ID: 38217825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
    Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
    Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.